FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210366066> ?p ?o ?g. }

• W4210366066 endingPage "3287" @default.
• W4210366066 startingPage "3272" @default.
• W4210366066 abstract "There is significant interest in the potential for nebulised unfractionated heparin (UFH), as a novel therapy for patients with COVID-19 induced acute hypoxaemic respiratory failure requiring invasive ventilation. The scientific and biological rationale for nebulised heparin stems from the evidence for extensive activation of coagulation resulting in pulmonary microvascular thrombosis in COVID-19 pneumonia. Nebulised delivery of heparin to the lung may limit alveolar fibrin deposition and thereby limit progression of lung injury. Importantly, laboratory studies show that heparin can directly inactivate the SARS-CoV-2 virus, thereby prevent its entry into and infection of mammalian cells. UFH has additional anti-inflammatory and mucolytic properties that may be useful in this context. METHODS AND INTERVENTION: The Can nebulised HepArin Reduce morTality and time to Extubation in Patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT) is a collaborative prospective individual patient data analysis of on-going randomised controlled clinical trials across several countries in five continents, examining the effects of inhaled heparin in patients with COVID-19 requiring invasive ventilation on various endpoints. Each constituent study will randomise patients with COVID-19 induced respiratory failure requiring invasive ventilation. Patients are randomised to receive nebulised heparin or standard care (open label studies) or placebo (blinded placebo-controlled studies) while under invasive ventilation. Each participating study collect a pre-defined minimum dataset. The primary outcome for the meta-trial is the number of ventilator-free days up to day 28 day, defined as days alive and free from invasive ventilation." @default.
• W4210366066 created "2022-02-08" @default.
• W4210366066 creator A5000527963 @default.
• W4210366066 creator A5003484494 @default.
• W4210366066 creator A5006917212 @default.
• W4210366066 creator A5013315693 @default.
• W4210366066 creator A5017990217 @default.
• W4210366066 creator A5019544175 @default.
• W4210366066 creator A5036034865 @default.
• W4210366066 creator A5037466209 @default.
• W4210366066 creator A5040327871 @default.
• W4210366066 creator A5045671873 @default.
• W4210366066 creator A5047955155 @default.
• W4210366066 creator A5048961690 @default.
• W4210366066 creator A5049303332 @default.
• W4210366066 creator A5072339799 @default.
• W4210366066 creator A5079231446 @default.
• W4210366066 creator A5083669907 @default.
• W4210366066 creator A5085336912 @default.
• W4210366066 creator A5091498476 @default.
• W4210366066 date "2022-02-20" @default.
• W4210366066 modified "2023-09-30" @default.
• W4210366066 title "Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies" @default.
• W4210366066 cites W1803784511 @default.
• W4210366066 cites W1969100385 @default.
• W4210366066 cites W1989039697 @default.
• W4210366066 cites W2000522086 @default.
• W4210366066 cites W2019353654 @default.
• W4210366066 cites W2091906456 @default.
• W4210366066 cites W2108696783 @default.
• W4210366066 cites W2159164274 @default.
• W4210366066 cites W2166023752 @default.
• W4210366066 cites W2286228001 @default.
• W4210366066 cites W2434367077 @default.
• W4210366066 cites W2466433766 @default.
• W4210366066 cites W2620241325 @default.
• W4210366066 cites W2897315557 @default.
• W4210366066 cites W2985938878 @default.
• W4210366066 cites W3007092620 @default.
• W4210366066 cites W3008028633 @default.
• W4210366066 cites W3011610993 @default.
• W4210366066 cites W3014294089 @default.
• W4210366066 cites W3016535995 @default.
• W4210366066 cites W3027918021 @default.
• W4210366066 cites W3028583791 @default.
• W4210366066 cites W3044455884 @default.
• W4210366066 cites W3044953630 @default.
• W4210366066 cites W3045233214 @default.
• W4210366066 cites W3045237152 @default.
• W4210366066 cites W3081487801 @default.
• W4210366066 cites W3082355253 @default.
• W4210366066 cites W3085153423 @default.
• W4210366066 cites W3097878033 @default.
• W4210366066 cites W3110820260 @default.
• W4210366066 cites W3113607491 @default.
• W4210366066 cites W3121998918 @default.
• W4210366066 cites W3165656738 @default.
• W4210366066 cites W3205438960 @default.
• W4210366066 cites W4206493500 @default.
• W4210366066 cites W4210366066 @default.
• W4210366066 cites W4226317263 @default.
• W4210366066 cites W4236805817 @default.
• W4210366066 cites W4237939525 @default.
• W4210366066 doi "https://doi.org/10.1111/bcp.15253" @default.
• W4210366066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35106809" @default.
• W4210366066 hasPublicationYear "2022" @default.
• W4210366066 type Work @default.
• W4210366066 citedByCount "8" @default.
• W4210366066 countsByYear W42103660662022 @default.
• W4210366066 countsByYear W42103660662023 @default.
• W4210366066 crossrefType "journal-article" @default.
• W4210366066 hasAuthorship W4210366066A5000527963 @default.
• W4210366066 hasAuthorship W4210366066A5003484494 @default.
• W4210366066 hasAuthorship W4210366066A5006917212 @default.
• W4210366066 hasAuthorship W4210366066A5013315693 @default.
• W4210366066 hasAuthorship W4210366066A5017990217 @default.
• W4210366066 hasAuthorship W4210366066A5019544175 @default.
• W4210366066 hasAuthorship W4210366066A5036034865 @default.
• W4210366066 hasAuthorship W4210366066A5037466209 @default.
• W4210366066 hasAuthorship W4210366066A5040327871 @default.
• W4210366066 hasAuthorship W4210366066A5045671873 @default.
• W4210366066 hasAuthorship W4210366066A5047955155 @default.
• W4210366066 hasAuthorship W4210366066A5048961690 @default.
• W4210366066 hasAuthorship W4210366066A5049303332 @default.
• W4210366066 hasAuthorship W4210366066A5072339799 @default.
• W4210366066 hasAuthorship W4210366066A5079231446 @default.
• W4210366066 hasAuthorship W4210366066A5083669907 @default.
• W4210366066 hasAuthorship W4210366066A5085336912 @default.
• W4210366066 hasAuthorship W4210366066A5091498476 @default.
• W4210366066 hasBestOaLocation W42103660661 @default.
• W4210366066 hasConcept C126322002 @default.
• W4210366066 hasConcept C151730666 @default.
• W4210366066 hasConcept C177713679 @default.
• W4210366066 hasConcept C2777080012 @default.
• W4210366066 hasConcept C2777557582 @default.
• W4210366066 hasConcept C2779343474 @default.
• W4210366066 hasConcept C42219234 @default.
• W4210366066 hasConcept C71924100 @default.

• next